Proteomics

Dataset Information

0

BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins


ABSTRACT: Colorectal cancer (CRC) is the third most commonly diagnosed cancer, which despite recent advances in treatment, remains incurable due to molecular heterogeneity of tumor cells. The B-cell lymphoma 9 (BCL9) oncogene functions as a transcriptional co-activator of the Wnt/β-catenin pathway, which plays critical roles in CRC pathogenesis. Here we have identified a β-catenin-independent function of BCL9 in a poor-prognosis subtype of CRC tumors characterized by expression of stromal and neural associated genes. In response to spontaneous calcium transients or cellular stress, BCL9 is recruited adjacent to the interchromosomal regions, where it stabilizes the mRNA of calcium signaling and neural associated genes by interacting with paraspeckle proteins. BCL9 subsequently promotes tumor progression and remodeling of the tumor microenvironment (TME) by sustaining the calcium transients and neurotransmitter-dependent communication among CRC cells. These data provide additional insights into the role of BCL9 in tumor pathogenesis and point towards additional avenues for therapeutic intervention.

INSTRUMENT(S): LTQ

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Colon Cancer

SUBMITTER: Meng Jiang  

LAB HEAD: Meng Jiang

PROVIDER: PXD016172 | Pride | 2020-05-27

REPOSITORIES: Pride

altmetric image

Publications

BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins.

Jiang Meng M   Kang Yue Y   Sewastianik Tomasz T   Wang Jiao J   Tanton Helen H   Alder Keith K   Dennis Peter P   Xin Yu Y   Wang Zhongqiu Z   Liu Ruiyang R   Zhang Mengyun M   Huang Ying Y   Loda Massimo M   Srivastava Amitabh A   Chen Runsheng R   Liu Ming M   Carrasco Ruben D RD  

Nature communications 20200107 1


Colorectal cancer (CRC) is the third most commonly diagnosed cancer, which despite recent advances in treatment, remains incurable due to molecular heterogeneity of tumor cells. The B-cell lymphoma 9 (BCL9) oncogene functions as a transcriptional co-activator of the Wnt/β-catenin pathway, which plays critical roles in CRC pathogenesis. Here we have identified a β-catenin-independent function of BCL9 in a poor-prognosis subtype of CRC tumors characterized by expression of stromal and neural assoc  ...[more]

Similar Datasets

2019-11-16 | GSE140488 | GEO
2011-12-01 | E-GEOD-29192 | biostudies-arrayexpress
2006-11-01 | GSE5517 | GEO
2011-12-01 | E-GEOD-29201 | biostudies-arrayexpress
2023-05-10 | PXD029743 | Pride
2016-05-13 | E-GEOD-77954 | biostudies-arrayexpress
2021-04-14 | PXD024343 | Pride
2020-05-26 | PXD014019 | Pride
2023-06-26 | GSE226635 | GEO
2018-06-14 | GSE114025 | GEO